Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 14 | 2024 | 64 | 2.340 |
Why?
|
| Humans | 60 | 2024 | 6794 | 1.550 |
Why?
|
| Male | 36 | 2024 | 3671 | 1.170 |
Why?
|
| Female | 32 | 2024 | 4060 | 1.120 |
Why?
|
| Adult | 33 | 2024 | 2113 | 1.110 |
Why?
|
| Acetaminophen | 6 | 2019 | 9 | 1.070 |
Why?
|
| Digoxin | 3 | 2016 | 3 | 0.930 |
Why?
|
| Energy Drinks | 2 | 2017 | 2 | 0.930 |
Why?
|
| Plant Poisoning | 1 | 2024 | 1 | 0.880 |
Why?
|
| Adolescent | 15 | 2024 | 869 | 0.870 |
Why?
|
| Manipulation, Osteopathic | 1 | 2024 | 1 | 0.870 |
Why?
|
| Stomach | 2 | 2015 | 8 | 0.810 |
Why?
|
| Middle Aged | 19 | 2024 | 2108 | 0.800 |
Why?
|
| Palliative Care | 1 | 2023 | 22 | 0.760 |
Why?
|
| Poison Control Centers | 4 | 2013 | 4 | 0.700 |
Why?
|
| Child | 10 | 2024 | 524 | 0.690 |
Why?
|
| Quality of Life | 1 | 2023 | 184 | 0.680 |
Why?
|
| Antivenins | 6 | 2011 | 9 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 73 | 0.650 |
Why?
|
| Cardiac Glycosides | 1 | 2020 | 1 | 0.650 |
Why?
|
| Apocynaceae | 1 | 2020 | 1 | 0.650 |
Why?
|
| Anti-Obesity Agents | 1 | 2020 | 4 | 0.640 |
Why?
|
| Child, Preschool | 9 | 2024 | 258 | 0.630 |
Why?
|
| Dietary Supplements | 1 | 2020 | 44 | 0.620 |
Why?
|
| Gastric Lavage | 1 | 2019 | 1 | 0.620 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 6 | 0.620 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 4 | 0.620 |
Why?
|
| Models, Biological | 2 | 2019 | 64 | 0.610 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 2016 | 4 | 0.580 |
Why?
|
| Hypnotics and Sedatives | 2 | 2014 | 7 | 0.560 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 43 | 0.520 |
Why?
|
| Young Adult | 6 | 2017 | 567 | 0.510 |
Why?
|
| Phenazopyridine | 1 | 2016 | 1 | 0.510 |
Why?
|
| Cystitis | 1 | 2016 | 4 | 0.510 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 6 | 0.510 |
Why?
|
| Pyelonephritis | 1 | 2016 | 3 | 0.510 |
Why?
|
| Drug Overdose | 4 | 2014 | 15 | 0.500 |
Why?
|
| Seafood | 2 | 2015 | 3 | 0.500 |
Why?
|
| Retrospective Studies | 10 | 2023 | 681 | 0.500 |
Why?
|
| Heroin | 1 | 2015 | 2 | 0.480 |
Why?
|
| Foreign Bodies | 1 | 2015 | 3 | 0.480 |
Why?
|
| Oxymetazoline | 1 | 2015 | 1 | 0.470 |
Why?
|
| Nasal Decongestants | 1 | 2015 | 1 | 0.470 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 4 | 0.470 |
Why?
|
| Marine Toxins | 2 | 2015 | 2 | 0.470 |
Why?
|
| Magnesium Sulfate | 2 | 2011 | 9 | 0.470 |
Why?
|
| Foodborne Diseases | 1 | 2015 | 1 | 0.460 |
Why?
|
| Tilapia | 1 | 2015 | 1 | 0.460 |
Why?
|
| Skin Absorption | 2 | 2009 | 3 | 0.460 |
Why?
|
| Snake Bites | 6 | 2000 | 9 | 0.450 |
Why?
|
| Chloral Hydrate | 1 | 2014 | 1 | 0.430 |
Why?
|
| Menstrual Hygiene Products | 1 | 2014 | 1 | 0.430 |
Why?
|
| California | 8 | 2012 | 230 | 0.430 |
Why?
|
| Alcoholic Beverages | 1 | 2014 | 3 | 0.430 |
Why?
|
| Infant | 5 | 2016 | 187 | 0.420 |
Why?
|
| Tablets | 2 | 2011 | 3 | 0.420 |
Why?
|
| Crotalid Venoms | 5 | 2000 | 6 | 0.390 |
Why?
|
| Aged | 8 | 2023 | 1539 | 0.380 |
Why?
|
| Spider Bites | 1 | 2011 | 1 | 0.360 |
Why?
|
| Black Widow Spider | 1 | 2011 | 1 | 0.360 |
Why?
|
| Spider Venoms | 1 | 2011 | 2 | 0.360 |
Why?
|
| Analgesics, Non-Narcotic | 4 | 2001 | 12 | 0.360 |
Why?
|
| Cathartics | 1 | 2011 | 1 | 0.350 |
Why?
|
| Magnesium | 1 | 2011 | 5 | 0.350 |
Why?
|
| Mass Behavior | 1 | 2011 | 1 | 0.350 |
Why?
|
| Somatoform Disorders | 1 | 2011 | 3 | 0.350 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2011 | 3 | 0.350 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 11 | 0.340 |
Why?
|
| Taurine | 1 | 2010 | 1 | 0.330 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 1 | 0.330 |
Why?
|
| Methadone | 1 | 2010 | 12 | 0.330 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 2 | 0.320 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 497 | 0.320 |
Why?
|
| Analgesics, Opioid | 1 | 2010 | 58 | 0.320 |
Why?
|
| Anaphylaxis | 2 | 2000 | 2 | 0.310 |
Why?
|
| Animals | 11 | 2015 | 1875 | 0.310 |
Why?
|
| Acrylamides | 1 | 2009 | 1 | 0.310 |
Why?
|
| Cnidarian Venoms | 1 | 2009 | 1 | 0.310 |
Why?
|
| Anthozoa | 1 | 2009 | 1 | 0.310 |
Why?
|
| Suicide, Attempted | 3 | 2010 | 14 | 0.300 |
Why?
|
| Carbamazepine | 2 | 1998 | 2 | 0.280 |
Why?
|
| Dextropropoxyphene | 2 | 1998 | 2 | 0.280 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 118 | 0.270 |
Why?
|
| Fatal Outcome | 2 | 2020 | 13 | 0.270 |
Why?
|
| Ethanol | 2 | 2014 | 86 | 0.240 |
Why?
|
| Dyspnea | 2 | 2023 | 6 | 0.230 |
Why?
|
| Allium | 1 | 2024 | 1 | 0.220 |
Why?
|
| Musculoskeletal Pain | 1 | 2024 | 1 | 0.220 |
Why?
|
| Area Under Curve | 4 | 2019 | 15 | 0.210 |
Why?
|
| Pain Management | 1 | 2024 | 27 | 0.210 |
Why?
|
| Administration, Rectal | 1 | 2024 | 1 | 0.210 |
Why?
|
| Methamphetamine | 1 | 2024 | 6 | 0.210 |
Why?
|
| Air Bags | 1 | 2003 | 2 | 0.200 |
Why?
|
| Burns, Chemical | 1 | 2003 | 4 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 506 | 0.200 |
Why?
|
| Charcoal | 2 | 2001 | 2 | 0.200 |
Why?
|
| Ireland | 1 | 2023 | 1 | 0.200 |
Why?
|
| Central Nervous System Stimulants | 2 | 2024 | 10 | 0.190 |
Why?
|
| Crotalus | 2 | 2000 | 4 | 0.190 |
Why?
|
| Risk Factors | 2 | 2017 | 767 | 0.190 |
Why?
|
| Pain | 1 | 2023 | 38 | 0.190 |
Why?
|
| Mouth Mucosa | 2 | 1999 | 13 | 0.190 |
Why?
|
| Hypercalcemia | 1 | 2002 | 11 | 0.180 |
Why?
|
| Vitamin D | 1 | 2002 | 45 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2011 | 331 | 0.180 |
Why?
|
| Clarithromycin | 2 | 1998 | 7 | 0.170 |
Why?
|
| Computer Communication Networks | 2 | 1998 | 7 | 0.170 |
Why?
|
| Mushroom Poisoning | 1 | 2000 | 1 | 0.170 |
Why?
|
| Internet | 1 | 2020 | 25 | 0.160 |
Why?
|
| Poisoning | 3 | 2015 | 7 | 0.160 |
Why?
|
| Iron Compounds | 1 | 1999 | 7 | 0.160 |
Why?
|
| Solubility | 1 | 2019 | 1 | 0.160 |
Why?
|
| Cephalexin | 1 | 1999 | 2 | 0.150 |
Why?
|
| Cephalosporins | 1 | 1999 | 4 | 0.150 |
Why?
|
| Hypokalemia | 2 | 2016 | 7 | 0.150 |
Why?
|
| Ipecac | 1 | 1999 | 1 | 0.150 |
Why?
|
| Self Administration | 1 | 1999 | 6 | 0.150 |
Why?
|
| Lithium | 1 | 1999 | 4 | 0.150 |
Why?
|
| Beer | 1 | 1999 | 4 | 0.150 |
Why?
|
| Pemoline | 1 | 1998 | 1 | 0.140 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1998 | 2 | 0.140 |
Why?
|
| Antitussive Agents | 1 | 1998 | 1 | 0.140 |
Why?
|
| Dextromethorphan | 1 | 1998 | 2 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1998 | 5 | 0.140 |
Why?
|
| Quinine | 1 | 1998 | 1 | 0.140 |
Why?
|
| Blindness | 1 | 1998 | 11 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 1999 | 145 | 0.140 |
Why?
|
| Crack Cocaine | 1 | 1997 | 5 | 0.140 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2012 | 14 | 0.140 |
Why?
|
| Midazolam | 1 | 1997 | 3 | 0.130 |
Why?
|
| Barbiturates | 1 | 1997 | 1 | 0.130 |
Why?
|
| Chlorobutanol | 1 | 1996 | 1 | 0.130 |
Why?
|
| Diflunisal | 1 | 1996 | 1 | 0.130 |
Why?
|
| Salicylates | 1 | 1996 | 1 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 280 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 53 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 58 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 25 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 1996 | 1 | 0.120 |
Why?
|
| Tetracycline | 1 | 1996 | 2 | 0.120 |
Why?
|
| Acute Disease | 4 | 2004 | 91 | 0.120 |
Why?
|
| Muscular Diseases | 2 | 2011 | 5 | 0.120 |
Why?
|
| Disease Progression | 1 | 2016 | 170 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2016 | 2 | 0.120 |
Why?
|
| Musculoskeletal System | 1 | 1996 | 4 | 0.120 |
Why?
|
| Crime | 1 | 2015 | 7 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 57 | 0.120 |
Why?
|
| Refrigeration | 1 | 2015 | 1 | 0.120 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 72 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2015 | 197 | 0.110 |
Why?
|
| Administration, Intravaginal | 1 | 2014 | 4 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 33 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2014 | 21 | 0.110 |
Why?
|
| Viperidae | 3 | 1999 | 3 | 0.110 |
Why?
|
| Household Products | 1 | 2013 | 1 | 0.100 |
Why?
|
| Product Labeling | 1 | 2013 | 1 | 0.100 |
Why?
|
| Emergency Treatment | 1 | 2013 | 2 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2012 | 81 | 0.100 |
Why?
|
| Emergencies | 3 | 2003 | 11 | 0.100 |
Why?
|
| Death | 1 | 2012 | 1 | 0.100 |
Why?
|
| Prescription Drugs | 1 | 2012 | 7 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2014 | 500 | 0.090 |
Why?
|
| Paresthesia | 1 | 2011 | 2 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2011 | 167 | 0.090 |
Why?
|
| Fatigue | 1 | 2011 | 7 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 197 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2011 | 13 | 0.090 |
Why?
|
| Constipation | 1 | 2011 | 7 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 12 | 0.090 |
Why?
|
| Administration, Oral | 3 | 2000 | 54 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 79 | 0.090 |
Why?
|
| Fasting | 1 | 2011 | 31 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2011 | 38 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2011 | 89 | 0.080 |
Why?
|
| Veterinary Drugs | 1 | 2010 | 1 | 0.080 |
Why?
|
| Pentobarbital | 1 | 2010 | 2 | 0.080 |
Why?
|
| Neuralgia | 1 | 2010 | 5 | 0.080 |
Why?
|
| Drug Recalls | 1 | 2010 | 1 | 0.080 |
Why?
|
| Drug Industry | 1 | 2010 | 5 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 42 | 0.080 |
Why?
|
| Vomiting | 2 | 1998 | 4 | 0.070 |
Why?
|
| Drug Combinations | 2 | 1998 | 20 | 0.070 |
Why?
|
| Drug Interactions | 2 | 1998 | 27 | 0.070 |
Why?
|
| Medication Errors | 1 | 2002 | 3 | 0.050 |
Why?
|
| Seizures | 1 | 2002 | 16 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2004 | 102 | 0.040 |
Why?
|
| Carbonated Beverages | 1 | 2001 | 3 | 0.040 |
Why?
|
| Amanita | 1 | 2000 | 1 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2000 | 5 | 0.040 |
Why?
|
| Diphenhydramine | 1 | 2000 | 1 | 0.040 |
Why?
|
| Epinephrine | 1 | 2000 | 9 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2000 | 2 | 0.040 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1999 | 1 | 0.040 |
Why?
|
| Swine | 1 | 1999 | 8 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 56 | 0.040 |
Why?
|
| Vitamins | 1 | 1999 | 14 | 0.040 |
Why?
|
| Pharmacies | 1 | 1999 | 5 | 0.040 |
Why?
|
| Medical Errors | 1 | 1999 | 3 | 0.040 |
Why?
|
| Viper Venoms | 1 | 1999 | 1 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 1999 | 4 | 0.040 |
Why?
|
| Random Allocation | 1 | 1999 | 27 | 0.040 |
Why?
|
| Drug Utilization | 1 | 1999 | 8 | 0.040 |
Why?
|
| Breath Tests | 1 | 1999 | 7 | 0.040 |
Why?
|
| Fishes | 1 | 1999 | 9 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 231 | 0.040 |
Why?
|
| Methazolamide | 1 | 1998 | 1 | 0.040 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1998 | 2 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1998 | 14 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1998 | 1 | 0.040 |
Why?
|
| Toxicology | 1 | 1998 | 1 | 0.040 |
Why?
|
| Anorexia | 1 | 1998 | 8 | 0.040 |
Why?
|
| Health Resources | 1 | 1998 | 12 | 0.040 |
Why?
|
| Long QT Syndrome | 1 | 1998 | 1 | 0.030 |
Why?
|
| Tinnitus | 1 | 1998 | 3 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1998 | 4 | 0.030 |
Why?
|
| Deafness | 1 | 1998 | 6 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 84 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 1998 | 61 | 0.030 |
Why?
|
| Tachycardia | 1 | 1997 | 2 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 1997 | 2 | 0.030 |
Why?
|
| Finger Injuries | 1 | 1997 | 2 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 7 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 1997 | 7 | 0.030 |
Why?
|
| Eating | 1 | 1997 | 31 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 5 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 1997 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 155 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 27 | 0.030 |
Why?
|
| Enzyme Multiplied Immunoassay Technique | 1 | 1997 | 1 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1997 | 2 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 1996 | 1 | 0.030 |
Why?
|
| Ulcer | 1 | 1996 | 3 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| First Aid | 1 | 2013 | 1 | 0.030 |
Why?
|
| Travel | 1 | 2010 | 6 | 0.020 |
Why?
|
| United States | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 599 | 0.020 |
Why?
|
| Absorption | 1 | 2001 | 5 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 27 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 63 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1999 | 1 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1999 | 4 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1999 | 3 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 6 | 0.010 |
Why?
|
| Recurrence | 1 | 1999 | 55 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1999 | 1 | 0.010 |
Why?
|
| Ciguatera Poisoning | 1 | 1999 | 1 | 0.010 |
Why?
|
| Shellfish Poisoning | 1 | 1999 | 1 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1999 | 3 | 0.010 |
Why?
|
| Paralysis | 1 | 1999 | 2 | 0.010 |
Why?
|
| Half-Life | 1 | 1998 | 4 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 7 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 1998 | 10 | 0.010 |
Why?
|
| Time Factors | 1 | 1999 | 321 | 0.010 |
Why?
|
| Urinalysis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Erythromycin | 1 | 1997 | 1 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 9 | 0.010 |
Why?
|
| Albuminuria | 1 | 1998 | 31 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1998 | 285 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 36 | 0.010 |
Why?
|
| Sheep | 1 | 1997 | 132 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 54 | 0.010 |
Why?
|